The patent describes an extremely innovative and precise method for identifying rare genetic variants within biological ...

Mayo Clinic's Precision Mouse Engineering Core in Minnesota produces CRISPR/Cas9-mediated knockout and point mutant mice for researchers.

The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

YolTech's gene therapy is intended as a one-time life-long cure for patients living with PH1, which can lead to kidney ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

SNIPR BIOME ApS (“SNIPR” or “the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent EP4392563B on February 24th 2025 by the European Patent ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

Call for Papers! Cas12-mediated Genome Editing in Plants . Ca. 01. Time Schedule . Submission deadline: Sunday, 30th November ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...